Absence seizures in succinic semialdehyde dehydrogenase deficient mice: A model of juvenile absence epilepsy

Pharmacology Biochemistry and Behavior

Volumn 79, Issue 3, 2004, Pages 547-553

  Cortez, M A ^a,b   Wu, Y ^a   Gibson, K M ^c   Snead III, O C ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Aminobutyric acid (GABA); Hydroxybutyric acid (GHB); Absence like seizures; Brain; ECoG; Generalized convulsive seizures; SSADH deficiency; Status epilepticus

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; ETHOSUXIMIDE; PROTEIN P14; PROTEIN P18; SUCCINATE SEMIALDEHYDE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE COURSE; ELECTROCORTICOGRAPHY; ELECTRODE; EPILEPSY; EPILEPTIC STATE; HUMAN; HYPOTHESIS; MOLECULAR MECHANICS; MOUSE; MYOCLONUS SEIZURE; NONHUMAN; PATHOGENESIS; PERINATAL PERIOD; PHENOTYPE; PRIORITY JOURNAL; RODENT; SEIZURE; SPIKE WAVE; TONIC CLONIC SEIZURE;

ALDEHYDE OXIDOREDUCTASES; ANIMALS; DISEASE MODELS, ANIMAL; EPILEPSY, ABSENCE; GABA ANTAGONISTS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SUCCINATE-SEMIALDEHYDE DEHYDROGENASE;

ANIMALIA; RODENTIA;

EID: 9644269233     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2004.09.008     Document Type: Article

References (38)

1. F. Bartolomei, J. Roger, and M. Bureau Prognostic factors for childhood and juvenile absence epilepsies Eur. Neurol. 37 1997 169 175
2. +-dependent uptake system for gamma-hydroxybutyrate in membrane vesicles prepared from rat brain J. Neurol. 38 1982 1570 1575
3. R. Bernasconi, P. Mathivet, U. Otten, B. Bettler, S. Bischoff, and C. Marescaux Part of the pharmacological actions of gamma-hydroxybutyrate are mediated by GABAB receptors G. Tunnicliff C. Cash Gamma-hydroxybutyrate 2002 Taylor and Francis New York 28 63
4. BxR) function and lethal status epilepticus in mice deficient for succinic semialdehyde dehydrogenase Abstr. - Soc. Neurosci. 2003 303.2. 2003 Online
5. M.A. Cortez, C. McKerlie, and O.C. Snead III A model of atypical absence seizures: EEG, pharmacology and developmental characterization Neurology 56 2001 341 349
6. V. Crunelli, and N. Leresche Childhood absence epilepsy: genes, channels, neurons and networks Nat. Rev., Neurosci. 3 2002 371 382
7. A. Depaulis, O.C. Snead III, C. Marescaux, and M. Vergnes Suppressive effects of intranigral injection of muscimol in three models of generalized non-convulsive epilepsy induced by chemical agents Brain Res. 498 1989 64 72
8. A. Dervent, K.M. Gibson, P.L. Pearl, G.S. Salomons, C. Jakobs, and C. Yalcinkaya Photosensitive absence epilepsy with myoclonias and heterozygosity for succinic semialdehyde dehydrogenase (SSADH) deficiency Clin. Neurophysiol. 1153 2004 1417 1422
9. K. Franklin, and G. Paxinos The mouse brain in stereotaxic coordinates 1997 Academic Press San Diego
10. N. Gervasi, Z. Monnier, P. Vincent, D. Paupardin-Tritsch, S.W. Hughes, and V. Crunelli Pathway-specific action of gamma-hydroxybutyric acid in sensory thalamus and its relevance to absence seizures J. Neurosci. 23 2003 11469 11478
11. K.M. Gibson, and C. Jacobs Disorders of beta- and gamma-amino acids in free and peptide-linked forms 8th ed. C.R. Scriver A.L. Beaudet W.S. Sly D. Valle The Metabolic and Molecular Bases of Inherited Disease vol. 91 2001 McGraw Hill New York 2079 2105
12. K.M. Gibson, L. Sweetman, W.L. Nyhan, C. Jakobs, D. Ratind, and H. Siemes Succinic semialdehyde dehydrogenase deficiency: an inborn error of gamma amino butyric acid metabolism Clin. Chim. Acta 133 1983 33 42
13. K.M. Gibson, E. Christensen, C. Jakobs, B. Fowler, M.A. Clarke, and G. Hammersen The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients Pediatrics 99 1997 567 574
14. K.M. Gibson, D.S. Schor, M. Gupta, W.S. Guerand, H. Senephansiri, and T.G. Burlingame Focal neurometabolic alterations in mice deficient for succinate semialdehyde dehydrogenase J. Neurochem. 81 2002 71 79
15. B.I. Gold, and R.H. Roth Kinetics of in vivo conversion of gamma-[3H] aminobutyric acid to gamma-[3H] hydroxybutyric acid by rat brain J. Neurochem. 28 1977 1069 1073
16. M. Gupta, R. Greven, E.E. Jansen, C. Jakobs, B.M. Hogema, and W. Froestl Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (gamma-hydroxybutyric aciduria) J. Pharmacol. Exp. Ther. 302 2002 180 187
17. B.M. Hogema, M. Gupta, H. Senephansiri, T.G. Burlingame, M. Taylor, and C. Jakobs Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase Nat. Genet. 29 2001 212 216
18. V.P. Kelly, P.J. Sherrat, D.H. Crouch, and J.D. Hayes Novel homodimeric and heterodimeric rat γ-hydroxybutyrate synthetases that associate with the golgi apparatus define a distinct subclass of aldo-keto reductase 7 proteins Biochem. J. 366 2002 847 861
19. P. Loiseau, B. Duche, and J.M. Pedespan Absence epilepsies Epilepsia 36 1995 1182 1186
20. W. Loscher, and M. Fiedler The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs: VI. Seasonal influences on maximal electroshock and pentylenetetrazole seizure thresholds Epilepsy Res. 25 1996 3 10
21. M. Maitre The γ-hydroxybutyrate signaling system in brain: organization and functional implications Progr. Neurobiol. 51 1997 337 361
22. T. Obeid Clinical and genetic aspects of juvenile absence epilepsy J. Neurol. 241 1994 487 491
23. C.P. Panayiotopoulos Absence epilepsies J. Engel T.A. Pedley Epilepsy: A Comprehensive Textbook 1997 Lippincott-Raven Philadelphia 2327 2346
24. P.L. Pearl, K.M. Gibson, M.T. Acosta, L.G. Vzina, W.H. Theodore, and M.A. Rogawski Clinical spectrum of succinic semialdehyde deficiency Neurology 60 2003 1413 1417
25. P.L. Pearl, E.J. Novotny, M.T. Acosta, C. Jacobs, and K.M. Gibson Succinic semialdehyde dehydrogenase deficiency in children and adults Ann. Neurol. 54 Suppl. 6 2003 S73 S80
26. O.C. Snead III Gamma-hydroxybutyrate model of generalized absence seizures: further characterization and comparison with other absence models Epilepsia 29 1988 361 368
27. O.C. Snead III The gamma-hydroxybutyrate model of absence seizures: correlation of regional brain levels of gamma-hydroxybutyric acid and gamma-butyrolactone with spike wave discharges Neuropharmacology 30 1991 161 167
28. O.C. Snead III Antiabsence seizure activity of specific GABAB and γ-hydroxybutyric acid receptor antagonists Pharmacol. Biochem. Behav. 53 1996 73 79
29. O.C. Snead III Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor J. Neurochem. 75 2000 1986 1996
30. O.C. Snead III γ-Hydroxybutyric acid and absence seizure activity G. Tunnicliff C.D. Cash Gamma hydroxybutyrate 2002 Taylor and Francis New York 132 141
31. A receptor function in the gamma-hydroxybutyrate model of generalized absence seizures Neuropharmacology 32 1993 401 409
32. O.C. Snead III, A. Depaulis, M. Vergnes, and C. Marescaux Absence epilepsy: advances in experimental animal models Adv. Neurol. 79 1999 253 278
33. O.C. Snead III, P.K. Banerjee, M. Burnham, and D. Hampson Modulation of absence seizures by the GABA(A) receptor: a critical role for metabotropic glutamate receptor 4 (mGluR4) J. Neurosci. 15 2000 6218 6224
34. N.J. Tillakaratne, L. Medina-Kauwe, and K.M. Gibson gamma-Aminobutyric acid (GABA) metabolism in mammalian neural and nonneural tissues Comp. Biochem. Physiol., A. Physiol. 112 1995 247 263
35. E.C. Wirrell Natural history of absence epilepsy in children Can. J. Neurol. Sci. 30 2003 184 188
36. C.G. Wong, T. Bottiglieri, and O.C. Snead III GABA, gamma-hydroxybutyric acid, and neurological disease Ann. Neurol. 54 Suppl. 6 2003 S3 S12
37. C.G. Wong, K.M. Gibson, and O.C. Snead III From the street to the brain: neurobiology of the recreational drug γ-hydroxybutyric acid Trends Pharmacol. Sci. 25 2004 29 34
38. A receptor: subunit-dependent functions and absence seizures Epilepsy Curr. 1 2001 1 5